Z-Medica Appoints Vinod Thourani, M.D. to Board of Directors

Wallingford, Conn.

(February 11, 2019)

Z-Medica, LLC, a Linden Capital Partners portfolio company and leading developer and manufacturer of hemostatic devices, announced today the appointment of nationally recognized cardiothoracic surgeon and researcher, Vinod Thourani, M.D., to the Board of Directors. Dr. Thourani currently serves as Professor of Surgery at Georgetown University School of Medicine and the Chairman of Cardiac Surgery for MedStar Heart & Vascular Institute, overseeing all cardiac surgical services at MedStar Washington Hospital Center in Washington, D.C. and MedStar Union Memorial Hospital in Baltimore, M.D.

“Throughout his distinguished career, Dr. Thourani has played a vital role in the development and refinement of cardiothoracic innovations, and we are honored to welcome him to our Board,” said Ernest Waaser, Chairman of Z-Medica and Linden Operating Partner. “His stellar reputation within the medical community, combined with his considerable experience guiding a number of significant clinical trials, will undoubtedly enable him to provide the Company – with unparalleled insight and guidance.”

Dr. Thourani is widely-admired throughout the cardiac surgery field for his work in structural heart disease and valve surgery, specifically Transcatheter Aortic Valve Replacement (TAVR) and minimally invasive aortic and mitral valvular surgery. Prior to joining MedStar in August 2017, he served as a professor of surgery and medicine at Emory Healthcare, Co-Director of the Emory Structural Heart and Valve Center and Chief of Cardiothoracic Surgery at Emory University Hospital Midtown in Atlanta, G.A.
 
“My passion for identifying new treatment solutions that make a positive impact on patient outcomes has fueled my career in cardiothoracic surgery,” said Dr. Thourani. “I look forward to applying that same passion to my role on the Board, and assisting Z-Medica as it continues to break new ground and develop innovative tools to control bleeding.”

During his tenure at Emory, Dr. Thourani focused on developing and refining innovative strategies and devices to treat structural heart disease, particularly in those patients who previously had no treatment alternatives. In addition, he played a pivotal role in directing a number of large clinical studies resulting in a significant expansion of the understanding of the valve disease and specifically use of TAVR, and served as the Director of the Advanced Trans catheter Valve Surgery Fellowship and a Fellow of the Woodruff Leadership Academy.

Dr. Thourani currently holds significant leadership positions in several major cardiology and cardiothoracic surgical associations, including a seat on the Board of Directors of the Society of Thoracic Surgeons. He also serves as a Fellow of the American College of Surgeons, the American Board of Thoracic Surgery, and the American College of Cardiology. Dr. Thourani obtained his B.S. from Furman University and received his M.D. at Emory University.

Dr. Thourani joins the Board of Directors of Z-Medica alongside healthcare executives; Chris Van Gorder, FACHE, President and Chief Executive Officer of Scripps Health; Ernest Waaser, Chairman of Z-Medica and Linden Operating Partner; and Stephen Fanning, former Chief Executive Officer of Z-Medica.

 

Our site includes links to third party sites in which the Z-Medica® Privacy Policy and Terms of Use do not apply. Please read the privacy policy for every third party website you visit.

Close Continue Close

top

We have placed cookies on your computer to give you the best possible experience with our website. These cookies are also used to ensure we show you advertising that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time.
Privacy Policy